CD73 Blockade Reverses Selinexor-Linked Immune Suppression
A peer-reviewed preclinical study from Peking University collaborators and Antengene identified CD73 upregulation as a potential adaptive immune-suppression mechanism after selinexor exposure. In a syngeneic J558 myeloma model, the ATG-037 CD73 inhibitor plus ATG-010…
